帕金森病中的线粒体功能障碍:对认知障碍的贡献?
Antonella Scorziello1, Rossana Sirabella1, Maria Josè Sisalli2
1Department of Neuroscience, Division of Pharmacology, Reproductive and Dentistry Sciences, School of Medicine, Federico II University of Naples, Via Pansini 5, 80131 Naples, Italy.
International journal of molecular sciences
|November 9, 2024
概括
帕金森病 (PD) 的认知障碍,从轻度到痴呆,涉及复杂的分子机制. 这篇评论探讨了线粒体功能障碍.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 神经学 神经学
背景情况:
- 认知障碍是帕金森病 (PD) 中普遍存在和使人失能的非运动症状.
- 在PD的认知衰退呈现异质,包括主观认知功能障碍 (SCD),轻度认知障碍 (MCI) 和帕金森病痴呆症 (PDD).
- 了解分子基础对于诊断,预后和治疗开发至关重要.
研究的目的:
- 研究导致帕金森病认知衰退的分子机制.
- 确定参与PD相关认知障碍的神经和分子通路.
- 为PD认知功能障碍的差异诊断,预后和治疗策略提供信息.
主要方法:
- 本综述综合了关于PD认知障碍分子机制的当前研究.
- 专注于线粒体在突触功能障碍和神经元恶化中的作用.
- 检查受影响的大脑区域,负责PD非运动症状.
主要成果:
- 线粒体功能障碍与PD中的突触缺陷和神经元损伤有关.
- 特定的分子通路有助于认知障碍的进展.
- 大脑对非运动功能至关重要的区域受到显著影响.
结论:
- 线粒体功能障碍是帕金森病认知障碍的关键因素.
- 阐明这些机制对于开发有针对性的疗法至关重要.
- 对分子通路的进一步研究可以改善患者的治疗结果和疾病管理.
相关概念视频
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Parkinson's Disease: Treatment
222
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
222
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Mitochondria
11.2K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
11.2K
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Mitochondrial Membranes
8.9K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
8.9K


